BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19446142)

  • 1. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of three stand-alone topical thrombins for surgical hemostasis.
    Cheng CM; Meyer-Massetti C; Kayser SR
    Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical bovine thrombin and adverse events: a review of the literature.
    Clark J; Crean S; Reynolds MW
    Curr Med Res Opin; 2008 Jul; 24(7):2071-87. PubMed ID: 18549663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
    Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
    J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical recombinant human thrombin in surgical hemostasis.
    Bowman LJ; Anderson CD; Chapman WC
    Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.
    Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA;
    J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
    Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J
    Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
    Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
    J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
    Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
    J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials.
    Singla NK; Foster KN; Alexander WA; Pribble JP
    Pharmacotherapy; 2012 Nov; 32(11):998-1005. PubMed ID: 23108631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated coagulopathy: a case report.
    Naoum JJ
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.
    Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH
    Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine thrombin: history, use, and risk in the surgical patient.
    Diesen DL; Lawson JH
    Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical use of recombinant human thrombin for operative hemostasis.
    Anderson CD; Bowman LJ; Chapman WC
    Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.
    Su Z; Izumi T; Thames EH; Lawson JH; Ortel TL
    J Lab Clin Med; 2002 Jun; 139(6):349-56. PubMed ID: 12066133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical thrombins: benefits and risks.
    Lomax C; Traub O
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
    Adams JD; Jones S; Brost BC
    J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.